Skip to content

STAGEWISE STRATEGIES CORP.: 10-Q filed 2025-05-01

What STAGEWISE STRATEGIES CORP. reported in its quarterly report filed 2025-05-01 (fiscal Q2 2025): 30 published measures, 79 facts as tagged in accession 0001999261-25-000010.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-01
Fiscal period
fiscal Q2 2025
Accession
0001999261-25-000010 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STAGEWISE STRATEGIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-31214,017USD
At 2024-09-30115,744USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-31200,572USD
At 2024-09-30145,330USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-3113,444USD
At 2024-12-3113,404USD
At 2024-09-30-29,586USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-03-3110,686USD
At 2024-09-3011,343USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-11,980USD90
2024-10-01 to 2025-03-3115,720USD182
2024-10-01 to 2024-12-3127,700USD92
2024-01-01 to 2024-03-31-5,971USD91
2023-10-01 to 2024-03-31-19,117USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-10-01 to 2025-03-31-17,138USD182
2023-10-01 to 2024-03-31-28,872USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-01-01 to 2025-03-3115,000USD90
2024-10-01 to 2025-03-3169,690USD182
2024-01-01 to 2024-03-312,700USD91
2023-10-01 to 2024-03-315,100USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-10-01 to 2025-03-3187,530USD182
2023-10-01 to 2024-03-3170,030USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-10-01 to 2025-03-31-71,050USD182
2023-10-01 to 2024-03-31-41,600USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-21,886USD
At 2024-09-30-37,606USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-03-314,859,633shares90
2024-10-01 to 2025-03-314,580,094shares182
2024-01-01 to 2024-03-314,000,000shares91
2023-10-01 to 2024-03-314,000,000shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-10-01 to 2025-03-310USD/shares182
2024-01-01 to 2024-03-310USD/shares91
2023-10-01 to 2024-03-310USD/shares183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-11,980USD90
2024-10-01 to 2025-03-3115,717USD182
2024-01-01 to 2024-03-31-5,972USD91
2023-10-01 to 2024-03-31-19,121USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-3110,686USD
At 2024-09-3011,343USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-31200,572USD
At 2024-09-30145,330USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-03-3113,250USD
At 2024-09-3013,500USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-03-3126,980USD90
2024-10-01 to 2025-03-3153,973USD182
2024-01-01 to 2024-03-318,672USD91
2023-10-01 to 2024-03-3124,221USD183

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-3115,000USD90
2024-10-01 to 2025-03-3169,690USD182
2024-01-01 to 2024-03-312,700USD91
2023-10-01 to 2024-03-315,100USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-03-3170,400USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-315,044,334shares
At 2024-09-304,134,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-3110,686USD
At 2024-09-3011,313USD
At 2024-03-31168USD
At 2023-09-30610USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-3130,286USD
At 2024-09-303,886USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-03-31-22,107USD
At 2023-12-31-16,136USD
At 2023-09-30-2,990USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-03-31161,684USD
At 2024-09-30104,401USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-10-01 to 2025-03-3115,720USD182
2023-10-01 to 2024-03-31-19,117USD183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-5,971USD91
2023-10-01 to 2023-12-31-13,146USD92

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-03-317,579USD90
2024-10-01 to 2025-03-3113,767USD182
2024-01-01 to 2024-03-313,627USD91
2023-10-01 to 2024-03-316,045USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-01-01 to 2024-03-311USD91
2023-10-01 to 2024-03-314USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-10-01 to 2024-03-312,600USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-10-01 to 2025-03-31-250USD182
2023-10-01 to 2024-03-31-18,400USD183

Inspect the source

Entity
STAGEWISE STRATEGIES CORP. / CIK 0001999261
Captured
2026-09-21T17:38:17.525Z
SEC response SHA-256
d9c4ce11ce0ea6e776e92b65308dbca49e9626e1ce3e23e6b3bdfc50e6bd093c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001999261.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))